isoproterenol has been researched along with l 2286 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartha, E; Czopf, L; Deres, P; Halmosi, R; Hantó, K; Hideg, K; Kálai, T; Kulcsár, G; Pálfi, A; Sümegi, B; Szabados, E; Tóth, A; Tóth, K | 1 |
| Deres, P; Gallyas, F; Halmosi, R; Hanto, K; Hideg, K; Kalai, T; Kulcsar, G; Palfi, A; Sumegi, B; Szabados, E; Szereday, Z; Toth, A; Toth, K | 1 |
2 other study(ies) available for isoproterenol and l 2286
| Article | Year |
|---|---|
The role of Akt and mitogen-activated protein kinase systems in the protective effect of poly(ADP-ribose) polymerase inhibition in Langendorff perfused and in isoproterenol-damaged rat hearts.
Topics: Animals; Energy Metabolism; Enzyme Inhibitors; Heart; Hydrogen Peroxide; Isoproterenol; Lipid Peroxidation; Male; Mitogen-Activated Protein Kinases; Myocardium; Perfusion; Phosphorylation; Piperidines; Poly(ADP-ribose) Polymerase Inhibitors; Protective Agents; Proteins; Quinazolines; Rats; Rats, Sprague-Dawley | 2005 |
PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3beta pathway.
Topics: Animals; Cardiomegaly; Collagen Type III; Electrocardiography; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Heart Failure; Isoproterenol; Male; Mitogen-Activated Protein Kinases; Myocardial Infarction; Natriuretic Peptide, Brain; Phosphorylation; Piperidines; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Protein Kinase C; Quinazolines; Rats; Rats, Sprague-Dawley; Signal Transduction; Ventricular Remodeling | 2006 |